| A molecular mechanism of artemisinin resistance in Plasmodium falciparum malaria. HKA Mbengue A1, Bhattacharjee S1, Pandharkar T1 (2nd author), Liu H2, Estiu ... Nature 520 (7549), 683-7, 2015 | 678 | 2015 |
| Design, synthesis, and studies of small molecule STAT3 inhibitors D Bhasin, K Cisek, T Pandharkar, N Regan, C Li, B Pandit, J Lin, PK Li Bioorganic & medicinal chemistry letters 18 (1), 391-395, 2008 | 127 | 2008 |
| Novel arylimidamides for treatment of visceral leishmaniasis MZ Wang, X Zhu, A Srivastava, Q Liu, JM Sweat, T Pandharkar, ... Antimicrobial Agents and Chemotherapy 54 (6), 2507-2516, 2010 | 101 | 2010 |
| Antileishmanial Activity of a Series of N2,N4-Disubstituted Quinazoline-2,4-diamines KS Van Horn, X Zhu, T Pandharkar, S Yang, B Vesely, M Vanaerschot, ... Journal of medicinal chemistry 57 (12), 5141-5156, 2014 | 82 | 2014 |
| Potent antiprotozoal activity of a novel semi-synthetic berberine derivative M Bahar, Y Deng, X Zhu, S He, T Pandharkar, ME Drew, ... Bioorganic & medicinal chemistry letters 21 (9), 2606-2610, 2011 | 53 | 2011 |
| Synthesis and Antiprotozoal Activity of Dicationic m-Terphenyl and 1,3-Dipyridylbenzene Derivatives DA Patrick, MA Ismail, RK Arafa, T Wenzler, X Zhu, T Pandharkar, ... Journal of medicinal chemistry 56 (13), 5473-5494, 2013 | 40 | 2013 |
| Identification of new antileishmanial leads from hits obtained by high-throughput screening X Zhu, T Pandharkar, K Werbovetz Antimicrobial agents and chemotherapy 56 (3), 1182-1189, 2012 | 32 | 2012 |
| Antileishmanial bis-arylimidamides: DB766 analogs modified in the linker region and bis-arylimidamide structure–activity relationships CS Reid, AA Farahat, X Zhu, T Pandharkar, DW Boykin, KA Werbovetz Bioorganic & medicinal chemistry letters 22 (22), 6806-6810, 2012 | 25 | 2012 |
| Studies on the antileishmanial mechanism of action of the arylimidamide DB766: azole interactions and role of CYP5122A1 T Pandharkar, X Zhu, R Mathur, J Jiang, TD Schmittgen, C Shaha, ... Antimicrobial agents and chemotherapy 58 (8), 4682-4689, 2014 | 23 | 2014 |
| Synthesis and pharmacological evaluation of mono-arylimidamides as antileishmanial agents X Zhu, AA Farahat, M Mattamana, A Joice, T Pandharkar, E Holt, ... Bioorganic & Medicinal Chemistry Letters 26 (10), 2551-2556, 2016 | 19 | 2016 |
| 8, 8-dialkyldihydroberberines with potent antiprotozoal activity M Endeshaw, X Zhu, S He, T Pandharkar, E Cason, KV Mahasenan, ... Journal of natural products 76 (3), 311-315, 2013 | 12 | 2013 |
| Imidazopyridazine analogues as anti-malarial PfPI3K inhibitors R Liu, T Pandharkar, I Safeukui, S Bhattacharjee, H Liu, O Wiest, K Haldar, ... ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY 255, 2018 | | 2018 |
| Studies on the Antileishmanial Mechanism of Action of the Arylimidamide DB766: Azole Interactions and Role of CYP5122A1 (vol 58, pg 4682, 2014) T Pandharkar, X Zhu, R Mathur, J Jiang, TD Schmittgen, C Shaha, ... ANTIMICROBIAL AGENTS AND CHEMOTHERAPY 62 (1), 2018 | | 2018 |
| Correction to Antileishmanial Activity of a Series of N2,N4-Disubstituted Quinazoline-2,4-diamines KS Van Horn, X Zhu, T Pandharkar, S Yang, B Vesely, M Vanaerschot, ... Journal of Medicinal Chemistry 59 (2), 775-775, 2016 | | 2016 |
| Mechanistic studies of anti-leishmanial arylimidamides T Pandharkar The Ohio State University, 2012 | | 2012 |
